LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

GEODE CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001214717)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 4,399,139 Value ($000) $2,367 Avg Close — Range —
Q4 2024
Shares 4,137,264 Value ($000) $2,648 Avg Close — Range —
Q3 2024
Shares 4,019,961 Value ($000) $5,549 Avg Close — Range —
Q2 2024
Shares 4,012,053 Value ($000) $5,819 Avg Close — Range —
Q1 2024
Shares 4,017,021 Value ($000) $8,959 Avg Close — Range —
Q4 2023
Shares 3,937,350 Value ($000) $7,639 Avg Close — Range —
Q3 2023
Shares 3,656,483 Value ($000) $5,376 Avg Close — Range —
Q2 2023
Shares 3,375,828 Value ($000) $10,735 Avg Close — Range —
Q1 2023
Shares 3,188,435 Value ($000) $7,525 Avg Close — Range —
Q4 2022
Shares 3,052,005 Value ($000) $11 Avg Close — Range —
Q3 2022
Shares 2,950,650 Value ($000) $21,628 Avg Close — Range —
Q2 2022
Shares 1,876,087 Value ($000) $12,232 Avg Close — Range —
Q1 2022
Shares 1,454,233 Value ($000) $7,343 Avg Close — Range —
Q4 2021
Shares 558,726 Value ($000) $4,324 Avg Close — Range —
Q3 2021
Shares 531,885 Value ($000) $7,871 Avg Close — Range —
Q2 2021
Shares 174,420 Value ($000) $2,832 Avg Close — Range —